Medication error management around the globe: An overview

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 5, 2010, Pages 539-545

  Patel, Isha ^a   Balkrishnan, R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Canada; Europe; India; medication error; role of communication; USA

Indexed keywords

CANADA; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EUROPE; HEALTH CARE PRACTICE; HUMAN; INDIA; MEDICATION ERROR; REVIEW; UNITED STATES;

EID: 79955097862     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.78518     Document Type: Review

References (35)

1. National coordinating council for medication error reporting and prevention. About Medication Errors. Available from: http://www. nccmerp.org/aboutMedErrors.html. [updated on 2008 Jan 8].
2. National coordinating council for medication error reporting and prevention. Press Releases. Available from: http://www.nccmerp.org/ press/press2003-11-25.html. [updated on 2008 Jan 8].
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-05. (Pubitemid 28193431)
4. Kohn LT, Corrigan JM, Donaldson MS. Institute of Medicine. To Err is Human: Building a Safer Health System. Washington DC: National Academy Press; 2000.
5. Altman DE, Clancy C, Blendon RJ. Improving patient safety-fi ve years after the IOM report. N Engl J Med 2004;351:2041.
6. Burke JP. Medication Errors. N Engl J Med 2007;357:624.
7. Institute of Medicine. Crossing the Quality Chasm: A New Health System for then 21st Century. Washington DC: National Academy Press; 2001.
8. Batalden PB, Mohr JJ. Building knowledge of health care as a system. Qual Manag Health Care 1997;5:1-12.
9. Orser B. Reducing medication errors. CMAJ 2000;162:1150-51. (Pubitemid 30246289)
10. Council of Europe. Creation of a better medication safety culture in Europe: Building up safe medication practices 2006. Available from: http://www.coe.int/t/e/social-cohesion/soc-sp/medication%20safety%20 culture%20report%20e.pdf. [updated on 2008 Nov 15].
11. 2005/06 Annual Report - Hospital Pharmacy in Canada. Ethics in Hospital Pharmacy. Available from: http://www.lillyhospitalsurvey. ca/hpc2/content/2006- report/mentalhospitals.pdf. [updated on 2008 Nov 15].
12. David U. Medication error reporting systems: Problems and Solutions. New Medicine. Available from: http://www.ismpcanada.org/download/ Medication%20Error%20Reporting%20Systems%20-%20Problems%20 and%20Solutions.pdf. [updated on 2008 Nov 15].
13. European Foundation for the Advancement of Health Practitioners. Available from: http://www.efahp.org/v2/about/about.php. [updated on 2008 Nov 17].
14. Castot A. The French pharmacovigilance system. Bratisl Lek Listy 1998;99:29-30.
15. Centre for Adverse Reactions Monitoring, New Zealand. Available from: http://carm.otago.ac.nz/CARM.asp. [updated on 2008 Nov 17].
16. USP. USP medication error reporting program. Available from: http:// www.usp.org/patientSafety/reporting/mer.html. [updated on 2008 Dec 1].
17. The Institute for Safe Medication Practices. USP launches MedMARx® as the third major national reporting program for adverse drug events. Available from: http://www.ismp.org/MSAarticles/MedMARx.html. [updated on 2008 Dec 1].
18. Balkrishnan R, Furberg CD. Developing an optimal approach to global drug safety. J Intern Med 2001;250:271-9. (Pubitemid 32955613)
19. Society of Pharmacovigilance, India. Available from: http://www. medbeats.com/sopi.html. [updated on 2008 Dec 3].
20. Ramesh M, Parthasarathi G. Adverse Drug Reactions reporting: Attitudes and perceptions of medical practitioners. Asian J Pharm Clin Res 2009;2:10-4.
21. Gor AP, Desai SV. Adverse drug reactions (ADR) in the inpatients of medicine department of a rural tertiary care teaching hospital and infl uence of pharmacovigilance in reporting ADR. Indian J Pharmacol 2008;40:37-40.
22. Kshirsagar NA, Olsson S, Ferner RE. Consideration of the desirable features and possible forms of practical indicators of the performance of pharmacovigilance centers. Int J Risk Saf Med 2010;22:59-66.
23. Dikshit RK, Desai C, Desai MK. Pleasures and pains of running a pharmacovigilance center. Indian J Pharmacol 2008;40:S31-S4.
24. Arora D. Pharmacovigilance obligations of the pharmaceutical companies in India. Indian J Pharmacol 2008;40:S13-S6.
25. UR 48, Uppsala reports January 2010, The Uppsala monitoring center, Sweden. Available from: http://www.who-umc.org/graphics/22435.pdf. [updated on 2010 Aug 15].
26. UR 46, Uppsala reports July 2009, The Uppsala monitoring center, Sweden. Available from: http://www.who-umc.org/graphics/21039.pdf. [updated on 2010 Aug 15].
27. Leape LL, Woods DD, Hatlie MJ, Kizer KW, Schroeder SA, Lundberg GD. Promoting patient safety by preventing medical error. JAMA 1998;280:1444-7. (Pubitemid 28496055)
28. Kuehn BM. IOM: overhaul drug safety monitoring. JAMA 2006;296:2075-6. (Pubitemid 44664688)
29. The ERICE Declaration On Communicating Information Drug Safety. Available from: http:/www.prescrire.org/docus/ericeEn.pdf. [updated on 2008 Dec 3].
30. Wood AJ. The safety of new medicines: the importance of asking the right questions. JAMA 1999;281:1753-4. (Pubitemid 29226487)
31. Herxheimer A, McPherson A, Miller R, Shepperd S, Yaphe J, Ziebland S. Database of patients' experiences (DIPEx): a multi-media approach to sharing experiences and information. Lancet 2000;355:1540-3. (Pubitemid 30237366)
32. Bowdler J. Effective communications in pharmacovigilance: The Erice Report. Birmingham, England: W Lake Limited; 1997.
33. U.S. Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Guidance Drug Safety Information - FDA's Communication to the Public. Available from: http://www.fda.gov/cder/ guidance/index.htm. [updated on 2008 Dec 3].
34. Gogtay N, Dalvi S, Kshirsagar N. Safety monitoring: An Indian perspective. Int J Risk Saf Med 2003;16:21-30. (Pubitemid 37475765)
35. Leape LL, Berwick DM. Five Years After To Err Is Human: What Have We Learned? JAMA 2005;293:2384-90.